ProteoMediX

ProteoMediX specializes in the identification of novel biomarkers for early cancer detection and personalized treatment. The first product currently under development is a blood-based test that can diagnose prostate cancer with higher accuracy than current clinical standards. This product reduces unnecessary biopsies, significantly saving costs for the healthcare system and minimizing patient discomfort.